PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Frontiers in Neurology0 citationsOpen Access

Neutrophil-to-apolipoprotein A1 ratio as a novel biomarker for prognosis in anti-NMDAR encephalitis: a retrospective cohort analysis

JZJinwei ZhangLLLing LingLXLei Xiang

Key Points

  • Neutrophil-to-apolipoprotein A1 ratio serves as an independent predictor of poor prognosis in anti-NMDAR encephalitis, enabling better patient stratification.
  • High specificity of this biomarker assists in early identification of high-risk patients, which is crucial for timely intervention.
  • Retrospective cohort analysis highlights the prognostic value of neutrophil-to-apolipoprotein A1 ratio, suggesting its potential role in future management strategies.
  • Identifying patients at risk of recurrence can improve long-term outcomes, calling for further exploration in clinical settings.

Abstract

NAR is an independent predictor of poor disease prognosis and risk of recurrence in patients with anti-NMDAR encephalitis. Its high specificity helps identify high-risk patients early and accurately, giving this biomarker long-term prognostic value.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69a75bb2c6e9836116a23857https://doi.org/10.3389/fneur.2026.1725493
Ask AI
Helpful
Bookmark
Share
View Full Paper